event:
On December 30, the National Medical Security Administration and the State Administration of Traditional Chinese Medicine issued the “Guiding Opinions on Medical Insurance Supporting the Inheritance and Innovative Development of Traditional Chinese Medicine” (hereinafter referred to as the “Opinions”).
Comments:
The core content of the “Opinions” includes: ① Medical insurance supports the inheritance, innovation and development of traditional Chinese medicine. It is the implementation of General Secretary Jinping’s important exposition on traditional Chinese medicine work, and the specific measures for good inheritance, development and utilization of traditional Chinese medicine. ②Promptly send qualified Chinese medicine (including integrated traditional Chinese and western medicine, ethnic minority medicine, the same below) medical institutions,traditional Chinese medicineRetail pharmacies, etc. are included in the management of designated medical insurance agreements. In a timely manner, qualified designated TCM medical institutions will be included in the designated scope of direct settlement for medical treatment in other places. ③For traditional Chinese medicine techniques that are derived from ancient classics, are still widely used, and have proven curative effects, as well as new Chinese medicine techniques with outstanding innovative and economic advantages, simplify the review procedures for newly added price items and open up a green channel.Traditional Chinese medicine whose cost and price deviate significantlymedical serviceThe project is included in the scope of price adjustment to reflect the value of labor services.traditional Chinese medicineDecoction pieces are sold strictly according to the purchase price plus no more than 25%; medical institutions concoct and usetraditional Chinese medicineDecoction pieces and prepared traditional Chinese medicine preparations are subject to independent pricing. Encourage the inclusion of traditional Chinese medicine formula granules purchased by public medical institutions into online transactions on the provincial centralized pharmaceutical procurement platform to promote openness and transparency of transactions. ④ Chinese herbal medicines, proprietary Chinese medicines, and traditional Chinese medicine preparations in medical institutions are eligible to be included in medical insurance.fundAffordability and clinical needs, the above products will be included in the scope of local medical insurance payment. The ultra-conventional doses of Chinese herbal medicines that meet the requirements are included in the scope of medical insurance payment. Encourage all localities to include appropriate TCM techniques with definite curative effects and characteristic advantages of TCM into the scope of medical insurance payment. Expenses of traditional Chinese medicine that meet the standards of epidemic diagnosis and treatment shall be included in medical insurance according to regulations. ⑤ TCM medical institutions may temporarily not implement DRG payment. For areas that have implemented DRG and disease-based payment, appropriately increase the coefficients and scores of TCM medical institutions and TCM disease types to fully reflect the Features and advantages of medical services.
Maintain recommended rating. After the release of the “Opinions”, we can see that the national policy supports the development of Chinese medicine from top to bottom, and various specific measures are continuously being implemented. ①The scope of medical insurance coverage terminal is fully expanded. It is expected that the medical insurance coverage of TCM products will increase.medical servicePrices are expected to increase. Chinese herbal medicines, proprietary Chinese medicines, and traditional Chinese medicine preparations in medical institutions will all enjoy marginal increases, and the positive effects of herbal medicines and in-hospital Chinese medicine preparations will be even greater. ② Chinese medicine decoction pieces still maintain an addition ratio of no more than 25%. my country’s TCM formula particles are included in the management of decoction pieces. In the future, the hospital channel of Chinese medicine formula particles is expected to continue to maintain a rapid growth trend. ③ TCM medical institutions will not implement DRG payment for the time being, and the implemented areas have appropriately increased the coefficients and scores of TCM disease types, indicating the government’s attitude towards TCM support and the strength of medical insurance to support TCM as a whole.It is recommended to continue to pay attention to those with brand value and exclusive product advantagesPien Tze Huang(600436)、China Resources Sanjiu(000999)、Yiling Pharmaceutical(002603)、Yunnan Baiyao(000538)、Tongrentang(600085)、Baiyun Mountain(600332)、Tasly(600535) and so on.
risk warning. The implementation progress of the Chinese medicine support policy is lower than expected, and the new crown epidemic affects the terminal sales of Chinese medicine OTC varieties.
(Article source: DongguanSecurities）
Article source: Dongguan Securities
Editor in charge: 3
Original title: Pharmaceutical and biological industry: Comments on events in the traditional Chinese medicine industry: “Guiding Opinions on Medical Insurance Supporting the Inheritance and Innovation and Development of Traditional Chinese Medicine” Released
Solemnly declare: The purpose of this information is to spread more information, and it has nothing to do with this stand.
report
Scan the QR code to follow
Oriental Wealth Official Website WeChat
.